Tulavi Therapeutics, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersLos Gatos, CA
US patents8
SAM.gov UEIZL17LZXJMG96
CAGE code19Y33
Incorporated inDE
- peripheral nerve surgery
- allay™ Hydrogel Cap
- fully absorbable Hydrogel Platform
- Schedule a Demo
- Request a Brochure
Named on the company’s own website, read JUL 29, 2026
What they make
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
8 US patents granted 2021–2024, 8 of them in the five years to SEP 2025.
Pharmaceuticals 7Medical technology 1
- Methods for forming a nerve barrierUS 12,096,941 · granted SEP 24, 2024
- Treatment of sepsis and related inflammatory conditions by local neuromodulation of the autonomic nervous systemUS 12,029,733 · granted JUL 9, 2024
- Devices for in situ formed nerve caps and/or nerve wrapsUS 11,944,717 · granted APR 2, 2024
- Methods, agents, and devices for local neuromodulation of autonomic nervesUS 11,918,595 · granted MAR 5, 2024
- Methods and devices for in situ formed nerve capUS 11,890,393 · granted FEB 6, 2024
Newest 5 shown · Granted to Tulavi Therapeutics, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Tulavi Therapeutics, INC. | Los Gatos | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


